Limited Availability of Lupus Laboratory Tests, Such As ANA, in Developing Nations Affects Global Usefulness of Criteria and Clinical Trials
American College of Rheumatology (ACR)According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA) test, are less often offered in developing nations due to a relative lack of resources.